Delivery Order SPE2DB22D3004-SPE2DB26FQ93V
Award Date 11/10/25
Potential Completion Date 11/12/25
Potential Value $9.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on August 28, 2025, for Dupixent 200 mg/1.14 mL pen injectors valued at $10,156.90. This is a firm fixed-price, competitively awarded delivery order with a completion date of August 29, 2025. The contract carries no set-aside designation, indicating open competition among qualified vendors. AmerisourceBergen Drug Corp is a major pharmaceutical...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $16,770.06 by the Defense Logistics Agency (DLA) on September 11, 2025, for the supply of Dupixent (dupilumab) 300 mg/2 mL pen injectors. This is a firm fixed-price, non-set-aside competitive award with an ultimate completion date of September 12, 2025. The pharmaceutical will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate headquarters and distribution hub for federal...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 14, 2025, for the supply of Dupixent 300 mg/2 mL pen injections with a ceiling value of $7,585.38 and an ultimate completion date of July 15, 2025. This is a firm fixed-price, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 22, 2025, for the supply of Dupixent 300 mg/2 mL pen injectors with a ceiling value of $18,961.13. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 25, 2025, and performance based in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $14,595.53 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on October 30, 2025, with an ultimate completion date of October 31, 2025. This non-competitive, firm fixed-price delivery order will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 7, 2025, for the supply of Dupixent 300 mg/2 ml pen injectors. This competitively awarded, firm fixed-price delivery order has a ceiling value of $27,543.60 and an ultimate completion date of August 8, 2025. The contract was executed with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a $41,074.11 delivery order by the Defense Logistics Agency (DLA) for Dupixent 300 mg/2 mL pen medications with a completion date of November 7, 2025. This competitive award was issued on November 6, 2025, under a firm fixed-price delivery order contract with no set-aside designation. The contract represents a continuation of AmerisourceBergen's substantial role in...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 18, 2025, for the supply of Dupixent 300 mg/2 ml pen injections with a ceiling value of $3,418.92. This is a firm fixed-price delivery order under a non-set-aside competitive procurement, with an ultimate completion date of August 19, 2025. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier...
- AmerisourceBergen Drug Corp was awarded a $22,553.16 delivery order by the Defense Logistics Agency on October 30, 2025, for the supply of Dupixent 300 mg/2 mL pen injectors. The award was made on a firm fixed-price basis with no set-aside designation, indicating the contract was competitively awarded. The vendor's place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of October 31, 2025. This delivery order represents a child contract under...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $22,154.31 by the Defense Logistics Agency (DLA) on September 3, 2025, for the supply of Dupixent 300 mg/2 ml pens. This firm fixed price, competitively awarded contract is a non-set-aside delivery order with an ultimate completion date of September 4, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's larger Indefinite...